Biovance Capital works closely with
entrepreneurs to build leading companies with transformative treatments for patients in need.
Please, only send us your project if it meets the following criteria:
Stage
We invest in early-stage companies at seed and Series A rounds across Europe, with a focus in Portugal, Spain, and Italy.
Technology
We require robust results in appropriate animal models and patentable assets before investing.
Team
Profound technical expertise is essential, preferably coupled with business/commercial experience. Team needs to be coachable, fast-paced and have a sense of urgency.
Market
Large target market with a clear regulatory pathway for approval, with favorable reimbursement and
pricing policies.
Exit Potential
Sectors with high VC/M&A/IPO activity with examples of previous profitable exits and several possible acquirers.